ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	17/78	191/7206	1.17549242388e-11
ko05340	Primary immunodeficiency	9/78	30/7206	1.51395668275e-11
ko05168	Herpes simplex infection	15/78	182/7206	6.63403107385e-10
ko05152	Tuberculosis	15/78	187/7206	9.70959705495e-10
ko05162	Measles	12/78	120/7206	4.48966167175e-09
ko04612	Antigen processing and presentation	10/78	77/7206	7.48240327565e-09
ko04621	NOD-like receptor signaling pathway	13/78	157/7206	9.83739044488e-09
ko04064	NF-kappa B signaling pathway	10/78	96/7206	6.52640949685e-08
ko05145	Toxoplasmosis	11/78	126/7206	8.68661226781e-08
ko05321	Inflammatory bowel disease (IBD)	8/78	56/7206	1.22219054478e-07
ko04630	Jak-STAT signaling pathway	11/78	132/7206	1.40507180383e-07
ko05164	Influenza A	12/78	167/7206	1.86428579149e-07
ko04217	Necroptosis	12/78	178/7206	3.74070430379e-07
ko04620	Toll-like receptor signaling pathway	9/78	100/7206	1.09616746295e-06
ko05140	Leishmaniasis	8/78	75/7206	1.23072203074e-06
ko05330	Allograft rejection	5/78	24/7206	4.72421032565e-06
ko05167	Kaposi's sarcoma-associated herpesvirus infection	11/78	191/7206	5.61825280947e-06
ko05144	Malaria	6/78	45/7206	7.70939207708e-06
ko04650	Natural killer cell mediated cytotoxicity	8/78	97/7206	8.70849983126e-06
ko05320	Autoimmune thyroid disease	5/78	29/7206	1.26525932224e-05
ko04210	Apoptosis	10/78	180/7206	2.1288210634e-05
ko05160	Hepatitis C	9/78	153/7206	3.62066319429e-05
ko04668	TNF signaling pathway	8/78	120/7206	4.1462908111e-05
ko04660	T cell receptor signaling pathway	8/78	124/7206	5.2469111004e-05
ko04145	Phagosome	9/78	162/7206	5.67655255016e-05
ko05142	Chagas disease (American trypanosomiasis)	8/78	130/7206	7.34780242187e-05
ko04380	Osteoclast differentiation	8/78	134/7206	9.10467479655e-05
ko05161	Hepatitis B	9/78	173/7206	9.45473353814e-05
ko04659	Th17 cell differentiation	7/78	106/7206	0.00013690078296
ko05133	Pertussis	6/78	87/7206	0.000333460938153
ko05169	Epstein-Barr virus infection	9/78	206/7206	0.000353380150981
ko05323	Rheumatoid arthritis	6/78	89/7206	0.000377219666957
ko04514	Cell adhesion molecules (CAMs)	7/78	130/7206	0.0004823242133
ko04672	Intestinal immune network for IgA production	4/78	37/7206	0.000639800572323
ko05146	Amoebiasis	6/78	99/7206	0.000667768071752
ko05310	Asthma	3/78	17/7206	0.000743821227648
ko05332	Graft-versus-host disease	3/78	18/7206	0.000885656198253
ko05166	HTLV-I infection	10/78	292/7206	0.00111843519022
ko05134	Legionellosis	5/78	74/7206	0.00117448396673
ko05416	Viral myocarditis	4/78	55/7206	0.00285212505824
ko04658	Th1 and Th2 cell differentiation	5/78	96/7206	0.00370587065052
ko04622	RIG-I-like receptor signaling pathway	4/78	62/7206	0.00440663834149
ko04940	Type I diabetes mellitus	3/78	32/7206	0.00482867519532
ko04062	Chemokine signaling pathway	7/78	201/7206	0.005861363969
ko01524	Platinum drug resistance	4/78	76/7206	0.00904605353974
ko04664	Fc epsilon RI signaling pathway	4/78	77/7206	0.00946475806795
ko05203	Viral carcinogenesis	8/78	277/7206	0.00981942692908
ko04666	Fc gamma R-mediated phagocytosis	5/78	122/7206	0.0101156204657
ko04932	Non-alcoholic fatty liver disease (NAFLD)	6/78	182/7206	0.0136610794596
ko04917	Prolactin signaling pathway	4/78	87/7206	0.0143585663224
ko04933	AGE-RAGE signaling pathway in diabetic complications	5/78	135/7206	0.015185270602
ko05132	Salmonella infection	4/78	98/7206	0.0213247273873
ko04670	Leukocyte transendothelial migration	5/78	151/7206	0.0234698965846
ko04071	Sphingolipid signaling pathway	5/78	162/7206	0.0305987322863
ko04066	HIF-1 signaling pathway	4/78	123/7206	0.0438651706367
ko05143	African trypanosomiasis	2/78	32/7206	0.0465423059572